Jakob Bjørner

Jakob Bjørner

Adjungeret professor


  1. 2019
  2. Udgivet

    DIRECT COMPARISON OF CERTOLIZUMAB PEGOL, ABATACEPT AND BIOSIMILAR INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED IN ROUTINE CARE. OBSERVATIONAL DATA FROM THE DANISH DANBIO REGISTRY ANALYZED LIKE A RANDOMIZED CLINICAL TRIAL

    Grøn, K., Glintborg, Bente, Nørgaard, M., Mehnert, F., Stergaard, M., Dreyer, L., Krogh, N. S., Bjørner, Jakob Bue & Hetland, Merete Lund, 2019, I: Annals of the Rheumatic Diseases. 78, Suppl 2, s. 1391-1391 SAT0595.

    Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningfagfællebedømt

ID: 35060639